ACTIVE

C.V.H.

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

513 k €

-6.7% YoY

Gross margin

562,8 k €

+0.3% YoY

Equity

1,6 M €

-6.3% YoY

What does C.V.H. do?

C.V.H. is a Private limited company incorporated in 2000. Its main activity is: Activities of holding companies. Its registered office is in Genappe.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0472.931.418

Incorporation

04/10/2000

Legal form

Private limited company

Registered office

Rue de Villers-la-Ville 78
1470 Genappe · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	562,8 k €	+0.3%	561,2 k €	+4.4%	537,6 k €	+3085%	-18 k €	-119%	95,9 k €	-6.5%	102,5 k €	+12.6%	91,1 k €	+8.5%	83,9 k €	+31.4%	63,9 k €	+14.4%	55,8 k €	+28.9%	43,3 k €	-51.0%	88,3 k €	+19.4%	74 k €	+0.3%	73,8 k €	-24.3%	97,4 k €	-1.0%	98,4 k €	-1.7%	100,1 k €	+4.2%	96,1 k €	+21.6%	79 k €	+16.4%	67,9 k €
EBITDA	562,7 k €	+0.5%	560,2 k €	+4.4%	536,4 k €	+2914%	-19,1 k €	-120%	94,6 k €	-6.6%	101,3 k €	+12.8%	89,8 k €	+8.6%	82,7 k €	+33.1%	62,1 k €	+15.5%	53,8 k €	+27.1%	42,3 k €	-51.5%	87,3 k €	+19.6%	73 k €	+0.3%	72,8 k €	-24.3%	96,1 k €	-0.7%	96,8 k €	-1.9%	98,7 k €	+4.6%	94,4 k €	+22.0%	77,4 k €	+15.5%	67 k €
Operating result	562,7 k €	+0.7%	559 k €	+4.4%	535,3 k €	+2749%	-20,2 k €	-122%	93,5 k €	+2.1%	91,5 k €	+12.7%	81,2 k €	+9.6%	74,1 k €	+33.1%	55,7 k €	+23.2%	45,2 k €	+6.7%	42,3 k €	-51.5%	87,3 k €	+19.6%	73 k €	+0.3%	72,8 k €	-24.1%	95,9 k €	-0.7%	96,6 k €	+2.4%	94,4 k €	+5.0%	89,8 k €	+23.4%	72,8 k €	+9.4%	66,6 k €
Net result	513 k €	-6.7%	550,1 k €	+6.4%	517,2 k €	-22.1%	664 k €	+618%	92,4 k €	-66.3%	274,5 k €	+316%	66 k €	+8.6%	60,8 k €	+61.8%	37,6 k €	+43.7%	26,1 k €	-26.2%	35,4 k €	-72.2%	127,2 k €	+217%	40,1 k €	-5.9%	42,6 k €	-85.2%	287 k €	+429%	54,2 k €	-2.8%	55,8 k €	-67.5%	171,8 k €	+305%	42,4 k €	+11.7%	38 k €
Balance sheet
Equity	1,6 M €	-6.3%	1,8 M €	+34.6%	1,3 M €	+66.1%	783 k €	-4.4%	819 k €	+12.7%	726,5 k €	+2.2%	711,2 k €	+10.2%	645,2 k €	+10.4%	584,4 k €	+6.9%	546,8 k €	+5.0%	520,7 k €	+7.3%	485,3 k €	+390%	99 k €	-77.0%	429,9 k €	+11.0%	387,3 k €	+286%	100,4 k €	-79.4%	486,1 k €	+13.0%	430,3 k €	-23.4%	561,5 k €	+8.2%	519,1 k €
Total assets	2 M €	-5.0%	2,1 M €	+23.9%	1,7 M €	+15.8%	1,5 M €	+79.6%	828,7 k €	+2.5%	808,1 k €	+1.0%	800,3 k €	+5.6%	757,9 k €	+4.3%	726,9 k €	+2.2%	711,1 k €	+0.4%	708,5 k €	+1.7%	696,7 k €	+0.2%	695,3 k €	+6.7%	651,6 k €	-1.3%	659,9 k €	-14.1%	767,9 k €	+6.5%	720,7 k €	+7.3%	671,6 k €	-16.3%	802,5 k €	+6.2%	755,6 k €
Cash	3,7 k €	-97.7%	161 k €	+4044%	3,9 k €	-82.3%	21,9 k €	-85.3%	148,7 k €	+297%	37,4 k €	-69.2%	121,5 k €	+135%	51,6 k €	+65.0%	31,3 k €	+129%	13,6 k €	-85.6%	94,8 k €	+80.8%	52,5 k €	+3.0%	51 k €	+600%	7,3 k €	-53.3%	15,6 k €	-87.2%	121,9 k €	+61.3%	75,6 k €	+225%	23,3 k €	-55.7%	52,5 k €	-51.5%	108,2 k €
Debts	388,7 k €	+0.6%	386,3 k €	-8.8%	423,5 k €	-39.9%	704,2 k €	+7135%	9,7 k €	-88.1%	81,6 k €	-8.4%	89,1 k €	-21.0%	112,7 k €	-20.9%	142,6 k €	-13.2%	164,3 k €	-12.5%	187,8 k €	-6.4%	200,5 k €	-65.7%	584,5 k €	+166%	219,5 k €	-9.4%	242,2 k €	-63.0%	654,1 k €	+196%	220,7 k €	+4.2%	211,9 k €	-6.3%	226 k €	+2.0%	221,6 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

MDV Pharma

Director · 0742.814.914

Represented by Marie DE VRIESE

Active

P.C.Phar

Director · 0694.910.671

Represented by PIERRE CLABOTS

Active

Ended mandates

Jean CLABOTS

Manager · since 30 mars 2011

Ended

Pascale VERVRANGEN

Manager · since 30 mars 2011

Ended

Jean CLABOTS

Manager · since 01 janvier 2010

Ended

Pascale VERVRANGEN

Manager · since 01 janvier 2010

Ended

At this address

Other companies at this address

Company	CBE no.
MDV Pharma● Active	0742.814.914
PHARMACIE CLABOTS● Active	0451.595.376
UTVA HOLDING PHARMA● Active	0650.881.975

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	18/06/2026	14/07/2025	17/07/2024	25/04/2023	23/03/2022	16/06/2021
General meeting	30/05/2026	30/06/2025	31/05/2024	23/03/2023	17/03/2022	10/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	30/05/2026	18/06/2026	French	PDF
Micro model	31/12/2024	30/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	31/05/2024	17/07/2024	French	PDF
Micro model	31/12/2022	23/03/2023	25/04/2023	French	PDF
Micro model	31/12/2021	17/03/2022	23/03/2022	French	PDF
Micro model	31/12/2020	10/05/2021	16/06/2021	French	PDF
Micro model	31/12/2019	30/06/2020	10/07/2020	French	PDF
Abridged model	31/12/2018	30/06/2019	14/08/2019	French	PDF
Abridged model	31/12/2017	27/06/2018	12/07/2018	French	PDF
Abridged model	31/12/2016	27/05/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	28/05/2016	16/08/2016	French	PDF
Abridged model	31/12/2014	30/05/2015	14/08/2015	French	PDF
Abridged model	31/12/2013	31/05/2014	22/08/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	18/06/2013	French	PDF
Abridged model	31/12/2011	26/05/2012	08/08/2012	French	PDF
Abridged model	31/12/2010	28/05/2011	17/08/2011	French	PDF
Abridged model	31/12/2009	29/05/2010	23/08/2010	French	PDF
Abridged model	31/12/2008	30/05/2009	09/07/2009	French	PDF
Abridged model	31/12/2007	31/05/2008	14/08/2008	French	PDF
Abridged model	31/12/2006	26/05/2007	20/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

MDV Pharma

Director · 0742.814.914

Represented by Marie DE VRIESE

Active

P.C.Phar

Director · 0694.910.671

Represented by PIERRE CLABOTS

Active

Ended mandates

Jean CLABOTS

Manager · since 30 mars 2011

Ended

Pascale VERVRANGEN

Manager · since 30 mars 2011

Ended

Jean CLABOTS

Manager · since 01 janvier 2010

Ended

Pascale VERVRANGEN

Manager · since 01 janvier 2010

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office28/03/2023
SIEGE SOCIAL
PDF
Other27/01/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates23/02/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates16/12/2019
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Other18/04/2014
DIVERS
PDF
Registered office08/04/2014
SIEGE SOCIAL - CAPITAL, ACTIONS
PDF
Mandates28/04/2011
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Capital / shares13/05/2008
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025513 k €↓
2024
Annual accounts 2024550,1 k €↑
2023
Annual accounts 2023517,2 k €↓
2022
Annual accounts 2022664 k €↑
2022
Name changeCVH
2021
Annual accounts 202192,4 k €↓
2020
Annual accounts 2020274,5 k €↑
2019
Annual accounts 201966 k €↑
2018
Annual accounts 201860,8 k €↑
2017
Annual accounts 201737,6 k €↑
2016
Annual accounts 201626,1 k €↓
2015
Annual accounts 201535,4 k €↓
2014
Annual accounts 2014127,2 k €↑
2013
Annual accounts 201340,1 k €↓
2012
Annual accounts 201242,6 k €↓
2011
Annual accounts 2011287 k €↑
2010
Annual accounts 201054,2 k €↓
2009
Annual accounts 200955,8 k €↓
2008
Annual accounts 2008171,8 k €↑
2007
Annual accounts 200742,4 k €↑
2006
Annual accounts 200638 k €
2006
Name changeC.V.H.
04/10/2000
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

C.V.H.

Overview

What does C.V.H. do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline